BioSpace News Archive

Year

• 2005
• 2006
• 2007
• 2008
• 2009
• 2010
• 2011
• 2012
• 2013
• 2014
• 2015
• 2016
• 2017
• 2018
• 2019
• 2020
• 2021
• 2022
• 2023
• 2024
• 2025

Month

• January
• February
• March
• April
• May
• June
• July
• August
• September
• October
• November
• December

Day

• 1
• 3
• 4
• 5
• 6
• 7
• 9
• 10
• 11
• 12
• 13
• 14
• 15
• 16
• 17
• 18
• 19
• 20
• 21
• 22
• 23
• 24
• 25
• 26
• 27
• 28
• 29
• 30

• BioMidwest

  Sensient Announces Conference Call - April 14, 2023

  Sensient Technologies Corporation will hold its conference call to discuss 2023 first quarter results at 8:30 a.m. CDT on Friday, April 28, 2023.

  April 14, 2023

   · 

  1 min read
• Business

  Teva to Host Conference Call to Discuss First Quarter 2023 Financial Results at 8 a.m. ET on May 10, 2023

  Teva Pharmaceutical Industries Ltd. announced that it will issue a press release on its first quarter 2023 financial results on Wednesday, May 10, 2023 at 7:00 a.m. ET.

  April 14, 2023

   · 

  2 min read
• Biotech Beach

  MEI Pharma Announces 1-for-20 Reverse Stock Split

  MEI Pharma, Inc., a clinical-stage pharmaceutical company focused on advancing new therapies for cancer, announced that its board of directors approved a 1-for-20 reverse stock split.

  April 14, 2023

   · 

  4 min read
• Business

  LivaNova Board of Directors Announce Leadership Changes

  LivaNova PLC, a market-leading medical technology and innovation company, announced that Damien McDonald has resigned as Chief Executive Officer.

  April 14, 2023

   · 

  3 min read
• Biotech Bay

  Predicine to Introduce PredicineALERT™ MRD Assay and Present Twelve Posters at AACR 2023 Conference

  Predicine, a global molecular insights company, announced that it will present data from 12 studies and introduce PredicineALERT™, a next-generation Minimal Residual Disease liquid biopsy assay at the 2023 AACR Conference on April 14-19, 2023.

  April 14, 2023

   · 

  3 min read
• Business

  Biomerica Reports Q3 Fiscal 2023 Results

  Biomerica, Inc., a global provider of advanced medical diagnostic and therapeutic products, announced its fiscal third quarter and nine month results ended February 28, 2023.

  April 14, 2023

   · 

  5 min read
• Genetown

  Geneius Biotechnology Announces Poster Presentation at the 2023 AACR Annual Meeting

  Geneius Biotechnology, Inc. announced the company will present a poster presentation at the upcoming American Association for Cancer Research Annual Meeting, taking place April 14-19, 2023, in Orlando, Florida.

  April 14, 2023

   · 

  4 min read
• Policy

  FDA Roundup: April 14, 2023

  The U.S. Food and Drug Administration is providing an at-a-glance summary of news from around the agency.

  April 14, 2023

   · 

  7 min read
• Biotech Bay

  Senti Bio to Participate in Upcoming Investor Conferences - April 14, 2023

  Senti Biosciences, Inc., a biotechnology company innovating next-generation cell and gene therapies using its proprietary Gene Circuit platform, announced its participation at the following investor conferences.

  April 14, 2023

   · 

  6 min read
• Biotech Beach

  Epic Sciences Raises $24M in Series G Financing to Continue Funding Commercialization of DefineMBC

  Epic Sciences, Inc., a privately held diagnostics company, has completed a $24 million Series G which together with its $43 million Series F financing, totals $67 million raised in the last twelve months.

  April 14, 2023

   · 

  3 min read